NASDAQ: WRAPWrap Technologies Inc Stock
$2.81+0.09 (+3.31%)
Updated Oct 31, 2025
WRAP Price
$2.81
Fair Value Price
-$2.12
Market Cap
$142.81M
52 Week Low
$1.20
52 Week High
$3.00
P/E
-13.38x
P/B
12.14x
P/S
24.41x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.24M
Earnings
-$9.23M
Gross Margin
53.4%
Operating Margin
-285.16%
Profit Margin
-311.3%
Debt to Equity
0.33
Operating Cash Flow
-$6M
Beta
1.15
Next Earnings
Nov 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A
WRAP Overview
Wrap Technologies, Inc., a public safety technology and services company, develops policing solutions to law enforcement and security personnel. The company develops BolaWrap 150, a hand-held remote restraint device that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 2016 and is based in Tempe, Arizona.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WRAP's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Scientific & Technical Instrument
Industry Rating
A
WRAP
Ranked#21 of 24
Ranked#21 of 24
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $143.71 | A | |
| $24.73 | A | |
| $11.01 | A |
Be the first to know about important WRAP news, forecast changes, insider trades & much more!
WRAP News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WRAP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WRAP ($2.81) is overvalued by 232.66% relative to our estimate of its Fair Value price of -$2.12 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
WRAP ($2.81) is not significantly undervalued (232.66%) relative to our estimate of its Fair Value price of -$2.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
WRAP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more WRAP due diligence checks available for Premium users.
Valuation
WRAP fair value
Fair Value of WRAP stock based on Discounted Cash Flow (DCF)
Price
$2.81
Fair Value
-$2.12
Undervalued by
232.66%
WRAP ($2.81) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
WRAP ($2.81) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
WRAP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
WRAP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-13.38x
Industry
8.34x
Market
41.55x
WRAP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
12.14x
Industry
3.61x
WRAP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WRAP's financial health
Profit margin
Revenue
$1.0M
Net Income
-$3.7M
Profit Margin
-384.5%
WRAP's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
WRAP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$15.6M
Liabilities
$3.9M
Debt to equity
0.33
WRAP's short-term assets ($11.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WRAP's short-term assets ($11.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WRAP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
WRAP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.9M
Investing
-$53.0k
Financing
$0.0
WRAP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
WRAP vs Scientific & Technical Instrument Stocks
Wrap Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.